[DELAYED CORONARY SURGERY FOR THE TREATMENT OF ACUTE MYOCARDIAL INFARCTION WITH ELEVATED ST SEGMENT]

Insights

Delayed transdermal coronary surgery (TCS) is effective for acute myocardial infarction (MI) patients when early treatment is unavailable. This reperfusion therapy strategy reduces complications and mortality in the critical post-MI period.

Area of Science:

  • Cardiology and Cardiovascular Surgery
  • Interventional Cardiology
  • Acute Myocardial Infarction Treatment

Background:

  • Early reperfusion therapy (RT) is crucial for acute myocardial infarction (MI) with ST-segment elevation.
  • Transdermal coronary surgery (TCS) is often unavailable during the recommended early treatment window.
  • Risk stratification is essential to guide reperfusion strategies in MI patients.

Purpose of the Study:

  • To develop algorithms for reperfusion therapy prioritizing delayed transdermal coronary surgery (TCS).
  • To assess the effectiveness of delayed TCS compared to other MI treatment strategies.
  • To evaluate the impact of delayed TCS on overall and cardiovascular mortality in MI patients.

Main Methods:

  • Comparative analysis of treatment strategies in 1245 acute ST-segment elevation MI patients (2003-2007).
  • Treatment groups included: early TCS, delayed TCS (24-72 hr), thrombolysis without TCS, and conservative therapy.
  • Long-term follow-up (5 years) assessed general and cardiovascular lethality in 474 patients.

Main Results:

  • Delayed TCS (24-72 hr post-MI) effectively prevents complications and reduces fatal outcomes.
  • The effectiveness of delayed TCS was demonstrated even when early intervention was not possible.
  • Delayed TCS is a viable option for patients with late admission or transfer from facilities lacking interventional cardiology.

Conclusions:

  • Unavailability of early transdermal coronary surgery (TCS) does not preclude its successful delayed application in high-risk acute myocardial infarction (MI) patients.
  • Delayed TCS significantly improves outcomes, reducing mortality in both early and late post-infarction periods.
  • This strategy offers a critical treatment option for acute MI patients admitted late or transferred from other institutions.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
363
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
391
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
378
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
637
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
389